Condition: Stroke · Sponsor: National Taiwan University Hospital
This is a single-blind randomized comparative efficacy study involving 54-72 participants with chronic stroke. Participants will be randomized into proximal priority robotic group or distal priority robotic group and receive 18 intervention sessions (90 min/d, 3 d/wk for 6 weeks). The Fugl-Meyer Assessment Upper Extremity subscale, Medical Research Council Scale, Revised Nottingham Sensory Assessment, and Wolf Motor Function Test will be administered at baseline, after treatment, and at the 3-month follow-up. Two-way repeated-measures analysis of variance and the Chi-Square Automatic Interaction Detector Method will be used to examine the comparative efficacy and predictors of outcome, respectively, after intervention.
This description comes directly from the study's public registry record.
Kehchung Lin, ScD · +886233668180 · kehchunglin@ntu.edu.tw
Always discuss trial participation with your own doctor first.
| National Taiwan University Hospital | Taipei, Taipei, Taiwan | Recruiting |
| Taipei Tzu Chi Hospital | New Taipei City, Taiwan | Recruiting |
| Fongyuan Hospital | Taichung, Taiwan | Recruiting |
| Taipei Municipal Wan Fang Hospital | Taipei, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04446273